Deploys opportunistic and growth capital across public and private markets with emphasis on small-cap equities, credit instruments and sponsor-backed private deals. Juniper Investment Company structures multi-asset portfolios for institutional and high-net-worth clients, blending active stock selection with direct lending and secondary positions to generate income and upside. Risk management centers on concentrated sector bets in financial services and technology, flexible duration in fixed income, and a governance-led approach to portfolio company oversight.
Deploys opportunistic and growth capital across public and private markets with emphasis on small-cap equities, credit instruments and sponsor-backed private deals. Juniper Investment Company structures multi-asset portfolios for institutional and high-net-worth clients, blending active stock selection with direct lending and secondary positions to generate income and upside. Risk management centers on concentrated sector bets in financial services and technology, flexible duration in fixed income, and a governance-led approach to portfolio company oversight.
Operates an opportunistic, multi-asset strategy blending small-cap equity alpha, direct lending, and sponsor-backed private investments to deliver income and capital appreciation. Focuses on concentrated sector exposures—financials and technology—with active stock selection, flexible fixed-income duration and selective secondary positions to enhance liquidity. Underwriting prioritizes governance, downside protection and sponsor alignment; capital allocation rotates between public and private pockets based on valuation dislocations and yield pick-up. Tailors mandates for institutional and high‑net‑worth clients with disciplined risk controls.
Operates an opportunistic, multi-asset strategy blending small-cap equity alpha, direct lending, and sponsor-backed private investments to deliver income and capital appreciation. Focuses on concentrated sector exposures—financials and technology—with active stock selection, flexible fixed-income duration and selective secondary positions to enhance liquidity. Underwriting prioritizes governance, downside protection and sponsor alignment; capital allocation rotates between public and private pockets based on valuation dislocations and yield pick-up. Tailors mandates for institutional and high‑net‑worth clients with disciplined risk controls.
| Trades 137 | Longs Won 110/137 80% | Profit Factor 9.36 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $4.48M |
| Average Win $2.33M | Best Trade (Aug 15) $41.85M | Sharpe Ratio -9.17 |
| Average Loss -$1.01M | Worst Trade (Sep 01) -$8.64M | Z-Score 3.58 (99.97%) |
| Commissions $0 | Avg. Trade Length 2y 5m 1w 5d | Expectancy $1.67M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.21% |
| Consecutive Losing Trades | 350 | 315 | 280 | 245 | 210 | 175 | 140 | 105 | 70 | 35 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
ALNT Alliant Energy Corporation | 762,305 | $20.23M | $84.93M | - | $64.7M | 319.92% | +1.577% |
ALOT Astronova Inc. | 535,203 | $7.36M | $15.47M | - | $8.11M | 110.21% | +0.035% |
AORT Artivion Inc. | 2.02M | $46.81M | $58.86M | - | $12.05M | 25.74% | +2.57% |
BSX Boston Scientific Corporation | 4,100 | $174,988 | $212,503 | - | $37,515 | 21.44% | +0.271% |
BVS Bioventus Inc. Class A | 6.94M | $54.27M | $98.96M | - | $44.68M | 82.34% | +2.664% |
LINC Lincoln Educational Services Corporation | 1.73M | $10.03M | $51.89M | - | $41.85M | 417.1% | -0.565% |
LYTS Lsi Industries Inc. | 781,399 | $14.1M | $19.43M | - | $5.33M | 37.8% | +0.081% |
MG Mistras Group Inc | 61,138 | $1.11M | $1.11M | - | -$7,336.56 | -0.66% | -1.309% |
OFIX Orthofix Medical Inc. | 4.44M | $63.91M | $45.94M | - | -$17.97M | -28.12% | +1.572% |
TWIN Twin Disc Inc. | 1.02M | $9.1M | $25.15M | - | $16.05M | 176.33% | +1.531% |